Skip to main content
ARDT
NYSE Trade & Services

New Class Action Alleges Ardent Health Misrepresented Receivables, Sets March 9 Deadline

feedReported by Acceswire
Sentiment info
Negative
Importance info
8
Price
$9.48
Mkt Cap
$1.357B
52W Low
$8.07
52W High
$15.55
Market data snapshot near publication time

summarizeSummary

A new securities fraud class action lawsuit has been filed against Ardent Health by Bleichmar Fonti & Auld LLP, alleging the company misrepresented its accounts receivable by delaying the recognition of uncollectable accounts through a '180-day cliff' policy. This follows a previous announcement of a class action lawsuit against the company. The lawsuit claims these alleged misrepresentations led to a significant 33% stock drop on November 13, 2025, after the company revealed a $43 million decrease in revenue and increased professional liability reserves. This development escalates the legal challenges and potential financial liabilities for Ardent Health. Investors have until March 9, 2026, to apply to be appointed as lead plaintiff in the case.

At the time of this announcement, ARDT was trading at $9.48 on NYSE in the Trade & Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $8.07 to $15.55. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Acceswire.


show_chartPrice Chart

Share this article

Copied!

feed ARDT - Latest Insights

ARDT
Apr 08, 2026, 4:17 PM EDT
Filing Type: DEF 14A
Importance Score:
7
ARDT
Mar 27, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
7
ARDT
Mar 04, 2026, 4:47 PM EST
Source: Dow Jones Newswires
Importance Score:
7
ARDT
Mar 04, 2026, 4:16 PM EST
Filing Type: 8-K
Importance Score:
8
ARDT
Mar 02, 2026, 3:07 PM EST
Source: Acceswire
Importance Score:
8